Cargando…
Evaluating Circadian Dysfunction in Mouse Models of Alzheimer’s Disease: Where Do We Stand?
Circadian dysfunction has been described in patients with symptomatic Alzheimer’s disease (AD), as well as in presymptomatic phases of the disease. Modeling this circadian dysfunction in mouse models would provide an optimal platform for understanding mechanisms and developing therapies. While numer...
Autores principales: | Sheehan, Patrick W., Musiek, Erik S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358444/ https://www.ncbi.nlm.nih.gov/pubmed/32733196 http://dx.doi.org/10.3389/fnins.2020.00703 |
Ejemplares similares
-
The Hippocampus and Imagining the Future: Where Do We Stand?
por: Addis, Donna Rose, et al.
Publicado: (2012) -
Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020) -
Editorial: Representational states in memory: where do we stand?
por: Öztekin, Ilke, et al.
Publicado: (2015) -
Mouse Models for Food Allergies: Where Do We Stand?
por: Schülke, Stefan, et al.
Publicado: (2019) -
Neurogenic Erectile Dysfunction. Where Do We Stand?
por: Thomas, Charalampos, et al.
Publicado: (2021)